Bulletin
Investor Alert

New York Markets Open in:

AgeX Therapeutics Inc.

ASE: AGE

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Nov 30, 2020, 6:08 p.m.

AGE
/zigman2/quotes/208090696/composite

$

1.70

Change

-0.07 -3.95%

Volume

Volume 107

Quotes are delayed by 20 min

/zigman2/quotes/208090696/composite

Previous close

$ 1.78

$ 1.77

Change

-0.01 -0.56%

Day low

Day high

$1.73

$1.89

Open

52 week low

52 week high

$0.67

$3.93

Open

Annual Financials for AgeX Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 2016201720182019 5-year trend
Sales/Revenue -1.67M1.4M1.4M1.73M
Cost of Goods Sold (COGS) incl. D&A -911,000685,000841,000998,500
COGS excluding D&A -66,0003,000306,00047,500
Depreciation & Amortization Expense -845,000682,000535,000951,000
Depreciation -238,000165,00058,000393,000
Amortization of Intangibles -607,000517,000477,000558,000
Gross Income -755,000719,000555,000729,500
2016201720182019 5-year trend
SG&A Expense -13.49M9.14M11M13.29M
Research & Development -7.87M5.27M5.35M5.35M
Other SG&A -5.62M3.87M5.65M7.94M
Other Operating Expense -----
Unusual Expense ---800,000-
EBIT after Unusual Expense ---(11.25M)-
Non Operating Income/Expense -(4.59M)1.79M3.4M294,000
Non-Operating Interest Income ---116,00029,000
Equity in Affiliates (Pretax) -----
Interest Expense -25,00012,000--
Gross Interest Expense -25,00012,000--
Interest Capitalized -----
Pretax Income -(17.36M)(6.64M)(7.73M)(12.24M)
Income Tax ----148,000
Income Tax - Current Domestic -----
Income Tax - Current Foreign ----148,000
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income -(17.36M)(6.64M)(7.73M)(12.38M)
Minority Interest Expense -(1.86M)(57,000)(229,000)(230,000)
Net Income -(15.49M)(6.58M)(7.5M)(12.15M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries -(15.49M)(6.58M)(7.5M)(12.15M)
Preferred Dividends -----
Net Income Available to Common -(15.49M)(6.58M)(7.5M)(12.15M)
EPS (Basic) -(0.43)(0.18)(0.21)(0.33)
Basic Shares Outstanding -35.83M35.83M34.91M37.27M
EPS (Diluted) -(0.43)(0.18)(0.21)(0.33)
Diluted Shares Outstanding -35.83M35.83M34.91M37.27M
EBITDA -(11.89M)(7.74M)(9.91M)(11.61M)
Link to MarketWatch's Slice.